My HPRA: Register

HIBERIX. HAEMOPHILUS TYPE B (HIB) VACCINE

N/A Pdr+Solv for Soln for Inj

GlaxoSmithKline (Ireland) LimitedPA1077/027/001

Main Information

Trade NameHIBERIX. HAEMOPHILUS TYPE B (HIB) VACCINE
Active SubstancesHAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE
TETANUS TOXOID
Strength N/A
Dosage FormPdr+Solv for Soln for Inj
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/027/001

Group Information

ATC CodeJ07AG51 Hemophilus influenzae B vaccines

Status

Authorised/WithdrawnAuthorised
Licence Issued11/06/1999
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.